Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
<p>Abstract</p> <p>Background</p> <p>Market Access Agreements (MAA) between pharmaceutical industry and health care payers have been proliferating in Europe in the last years. MAA can be simple discounts from the list price or very sophisticated schemes with inarguably...
Saved in:
Main Authors: | Jarosławski Szymon (Author), Toumi Mondher (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Welcome to the Journal of Market Access and Health Policy under MDPI Wings
by: Mondher Toumi
Published: (2024) -
Non-profit drug research and development: the case study of Genethon
by: Szymon Jarosławski, et al.
Published: (2019) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017) -
Quantifying the persisting orphan-drug shortage public health crisis in the United States
by: Szymon Jarosławski, et al.
Published: (2017) -
Pharmaceutical market access in emerging markets: concepts, components, and future
by: Anuj Kumar, et al.
Published: (2014)